Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-712P is a pseudogene corresponding to a nonfunctional genomic segment that resembles the U6 small nuclear RNA gene. U6 snRNA is an essential non-coding RNA component of the spliceosome, which catalyzes the removal of introns from pre-messenger RNA in eukaryotic cells[5]. Like many U6-derived pseudogenes, RNU6-712P is considered a genetic remnant with no known protein product or biological activity. Pseudogenes such as RNU6-712P typically do not have active roles in cellular functions, do not code for functional RNA or protein, and are not considered therapeutic drug targets[1]. Their presence may serve as evolutionary markers rather than functional biomolecules. No evidence currently links RNU6-712P specifically to disease or therapeutic applications, nor does it serve as a biomarker or have any safety concerns[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 712, pseudogene (RNU6-712P).